CEO David Trainer sat down with Chuck Jaffe of Money Life and to talk about our Danger Zone pick this past week: Danger Zone: Mondelez International (MDLZ).


Stop us if you’ve heard this story before: slowing organic revenue growth, questionable non-GAAP metrics, and a large investment by activist Bill Ackman. No, we’re not talking about Valeant Pharmaceuticals (VRX), which is down 53% since we put it in the Danger Zone in late February. This time, we’re talking about Mondelez International (MDLZ).

Photo Credit: (Flickr)

Leave a Reply

Your email address will not be published.